瓜氨酸化DNA结合抑制因子1是类风湿关节炎的新型自身抗原
本研究探讨DNA结合抑制因子1(ID-1)在类风湿关节炎(RA)成纤维样滑膜细胞(FLS)中的作用及其瓜氨酸化后的自身抗原性。研究发现ID-1调控FLS增殖和细胞因子分泌,并在RA关节中瓜氨酸化,诱导产生抗瓜氨酸化ID-1抗体,鉴定出关键精氨酸位点R33、R52和R121。
要点
- ID-1缺失抑制RA FLS生长并增加IL-6和IL-8产生。
- 瓜氨酸化ID-1存在于RA滑膜组织,RA血清和滑液中可检测到抗瓜氨酸化ID-1抗体。
- ID-1自身抗原性的关键精氨酸位点为R33、R52和R121。
核心结论
- ID-1在RA中调控FLS增殖和细胞因子分泌,且瓜氨酸化后成为自身抗原。
研究设计与样本
- 研究检测RA患者血清ID-1水平及英夫利昔单抗治疗前后变化,使用CRISPR/Cas9敲除RA FLS中的ID-1,并对RA滑液和滑膜组织进行ID-1免疫沉淀和瓜氨酸化检测。
- 对体外瓜氨酸化重组人ID-1进行LC-MS/MS定位瓜氨酸化位点,并用免疫斑点法分析RA和正常血清及滑液中的抗瓜氨酸化蛋白抗体。
主要发现
- RA患者血清ID-1水平与多个疾病参数正相关,英夫利昔单抗治疗后降低。
- ID-1缺失导致RA FLS生长减少,IL-6和IL-8产生显著增加。
- ID-1免疫耗竭显著降低RA滑液中瓜氨酸化残基水平,瓜氨酸化ID-1在RA滑膜组织匀浆中检测到(n=5样本;P<0.05)。
- 免疫斑点分析显示RA外周血血清(n=30样本;P<0.001)和滑液(n=18样本;P<0.05)中存在抗瓜氨酸化ID-1抗体,但正常外周血血清中未检测到。
- LC-MS/MS和免疫斑点反应性分析确定ID-1自身抗原性的关键精氨酸为R33、R52和R121。
临床怎么用
- ID-1及其瓜氨酸化形式可能作为RA的潜在生物标志物或治疗靶点,但需进一步验证。
局限性
- 样本量较小(滑膜组织n=5,血清n=30,滑液n=18),需扩大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the intrinsic role of inhibitor of DNA binding 1 (ID-1) in rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS) and to investigate whether ID-1 is citrullinated and autoantigenic in RA. METHODS: RA patient serum ID-1 levels were measured before and after infliximab treatment. RA FLS were transfected with a clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 9 construct targeting ID-1 to examine the effects of ID-1 deletion. RA synovial fluid (SF) and homogenized synovial tissue (ST) were immunoprecipitated for ID-1 and measured for citrullinated residues using an enzyme-linked immunosorbent assay and Western blotting. Liquid chromatography tandem mass spectrometry (LC-MS/MS) was performed on in vitro-citrullinated recombinant human ID-1 (cit-ID-1) to localize the sites of citrullination. Normal and RA sera and SF were analyzed by immunodot blotting for anti-citrullinated protein antibodies (ACPAs) to cit-ID-1. RESULTS: RA patient serum ID-1 levels positively correlated with several disease parameters and were reduced after infliximab treatment. RA FLS displayed reduced growth and a robust increase in interleukin-6 (IL-6) and IL-8 production upon deletion of ID-1. ID-1 immunodepletion significantly reduced the levels of citrullinated residues in RA SF, and citrullinated ID-1 was detected in homogenized RA ST (n = 5 samples; P < 0.05). Immunodot blot analyses revealed ACPAs to cit-ID-1 but not to native ID-1, in RA peripheral blood (PB) sera (n = 30 samples; P < 0.001) and SF (n = 18 samples; P < 0.05) but not in normal PB sera. Following analyses of LC-MS/MS results for citrullination sites and corresponding reactivity in immunodot assays, we determined the critical arginines in ID-1 for autoantigenicity: R33, R52, and R121. CONCLUSION: Novel roles of ID-1 in RA include regulation of FLS proliferation and cytokine secretion as well as autoantigenicity following citrullination.
引用
- Ohara RA, Edhayan G, Rasmussen SM, et al. Citrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis. Arthritis Rheumatol. 2019. PMID: 30861322. doi:10.1002/art.40886
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。